These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 16638698)

  • 1. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease.
    Celik Y; Dagli U; Kiliç MY; Törüner M; Ozen SC; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM
    Scand J Gastroenterol; 2006 May; 41(5):559-65. PubMed ID: 16638698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
    Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
    Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD; Bid HK; Ghoshal UC
    Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency.
    Castro-Santos P; Suarez A; López-Rivas L; Mozo L; Gutierrez C
    Am J Gastroenterol; 2006 May; 101(5):1039-47. PubMed ID: 16573780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms.
    Balding J; Livingstone WJ; Conroy J; Mynett-Johnson L; Weir DG; Mahmud N; Smith OP
    Mediators Inflamm; 2004 Jun; 13(3):181-7. PubMed ID: 15223609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IL-10 gene is not involved in the predisposition to inflammatory bowel disease.
    Klein W; Tromm A; Griga T; Fricke H; Folwaczny C; Hocke M; Eitner K; Marx M; Runte M; Epplen JT
    Electrophoresis; 2000 Nov; 21(17):3578-82. PubMed ID: 11271474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies.
    Koss K; Satsangi J; Fanning GC; Welsh KI; Jewell DP
    Genes Immun; 2000 Feb; 1(3):185-90. PubMed ID: 11196710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India.
    Mittal RD; Manchanda PK; Bid HK; Ghoshal UC
    J Gastroenterol Hepatol; 2007 Jun; 22(6):920-4. PubMed ID: 17565649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polymorphism of the microsatellites and tumor necrosis factor genes in chronic inflammatory bowel diseases].
    Heresbach D; Ababou A; Bourienne A; Alizadeh M; Quelvennec E; Pagenault M; Dabadie A; Berre NH; Campion JP; Launois B; Gosselin M; Genetet B; Bretagne JF; Semana G
    Gastroenterol Clin Biol; 1997; 21(8-9):555-61. PubMed ID: 9587492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-1beta-511 and IL-1RN*2 polymorphisms in inflammatory bowel disease: An Italian population study and meta-analysis of European studies.
    Corleto VD; Pagnini C; Margagnoni G; Guagnozzi D; Torre MS; Martorelli M; Latiano A; Annese V; Caprilli R; Delle Fave G
    Dig Liver Dis; 2010 Mar; 42(3):179-84. PubMed ID: 19643686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between a gene polymorphism of tumor necrosis factor and inflammatory bowel disease.
    Song Y; Wu KC; Zhang L; Hao ZM; Li HT; Zhang LX; Qiao TD; Li CN; Fan DM
    Chin J Dig Dis; 2005; 6(4):170-4. PubMed ID: 16246225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis.
    Bioque G; Bouma G; Crusius JB; Koutroubakis I; Kostense PJ; Meuwissen SG; Peña AS
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):105-10. PubMed ID: 8723412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is interleukin-6 important in inflammatory bowel disease?
    Koss K; Satsangi J; Welsh KI; Jewell DP
    Genes Immun; 2000 Feb; 1(3):207-12. PubMed ID: 11196713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease.
    Vijgen L; Van Gysel M; Rector A; Thoelen I; Esters N; Ceelen T; Vangoidsenhoven E; Vermeire S; Rutgeerts P; Van Ranst M
    Genes Immun; 2002 Nov; 3(7):400-6. PubMed ID: 12424621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD.
    Ishii T; Matsuse T; Teramoto S; Matsui H; Miyao M; Hosoi T; Takahashi H; Fukuchi Y; Ouchi Y
    Respir Med; 2000 Sep; 94(9):847-51. PubMed ID: 11001075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population.
    Vishnoi M; Pandey SN; Choudhuri G; Mittal B
    Cancer Genet Cytogenet; 2008 Oct; 186(2):63-8. PubMed ID: 18940468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. -137 (G/C) IL-18 promoter polymorphism in patients with inflammatory bowel disease.
    Haas SL; Andreas Koch W; Schreiber S; Reinhard I; Koyama N; Singer MV; Böcker U
    Scand J Gastroenterol; 2005 Dec; 40(12):1438-43. PubMed ID: 16316892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of IL-13 gene +2044G/A mutation in patients with inflammatory bowel disease].
    Waterman M; Karban A; Nesher S; Weiss B; Shamir R; Eliakim R
    Harefuah; 2006 Nov; 145(11):789-92, 864. PubMed ID: 17183946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.